A New Window of Opportunity to Prevent Cardiovascular and Cerebrovascular Diseases
October 22, 2014
Neuroimaging tests can reveal brain changes resulting from vascular disease risk factors before the appearance of any signs or symptoms of cardiovascular or cerebrovascular disease.
Researchers Find Boosting Depression-Causing Mechanisms in the Brain Increases Resilience, Surprisingly
April 17, 2014
New antidepressant approach potentially promotes natural resilence, fewer side effects.
Epigenetic Changes Color the Genomes of People with MS - Jessica Shugart
December 9, 2013
he chemical decorations that adorn DNA could sway the onset or severity of multiple sclerosis just as much as the DNA sequence itself, suggests a study published in Nature Neuroscience.
Four Researchers from Icahn School of Medicine at Mount Sinai Among the 400 Most Highly Influential Biomedical Researchers in the World
November 25, 2013
Powerful researchers include Dr. Dennis S. Charney, Dr. Carlos Cordon-Cardo, Dr. Valentin Fuster, and Dr. Eric J. Nestler.
Two Mount Sinai Physicians Elected to the Institute of Medicine
October 24, 2013
Diane E. Meier, MD and Pamela Sklar, MD, PhD, recognized for Outstanding Professional Achievement and Commitment to Service.
Mount Sinai Researchers Publish New Edition of Psychiatry "Bible"
August 7, 2013
In light of the accelerated pace of discovery in understanding psychiatric illnesses, experts from Mount Sinai have published the 4th edition of Neurobiology of Mental Illness.
Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration
May 22, 2013
Partnership will accelerate the pace of discovery and innovation in Biomedical Sciences.
Mount Sinai Researchers Identify Promising Drug Target for Depression
February 17, 2013
Decreased expression of a protein called Rac1 may be a primary cause of depression, according to a new study in human and mouse brains.
Facts about How Mount Sinai is Researching and Treating Brain Diseases
December 14, 2012
The Mount Sinai Medical Center is one of the world’s leading institutions in discovering better ways to prevent, diagnose, and treat serious brain diseases.
Short DNA Strands in the Genome May be Key to Understanding Human Cognition and Diseases
November 20, 2012
Previously discarded, human-specific “junk” DNA represents untapped resource in the study of diseases like Alzheimer’s and autism
Changes in Nerve Cells Caused by Social Isolation May Contribute to the Development of Mental Illness
November 11, 2012
Reduced production of myelin, a type of nerve fiber that is lost in diseases like MS, may also play a role in the development of mental illness.
Mount Sinai Researchers Unveil New Targets for Depression at Neuroscience 2012
October 15, 2012
Scientists presented important discoveries on the involvement of the immune system and dopamine on the onset of depression.
Mount Sinai Researchers Find Brain Mechanism Behind Opioid Addiction
October 5, 2012
Chronic morphine exposure has the opposite effect on the brain compared to cocaine in mice, providing new insight into the basis of opiate addiction
Mount Sinai Researcher Receives Prestigious National Institutes of Health Award
September 13, 2012
Anne Schaefer, MD, PhD, Assistant Professor of Neuroscience and Psychiatry, has been recognized with the Director's New Innovator Award.
Researchers Identify Area Of The Brain That Processes Empathy
September 1, 2012
An international team led by Mount Sinai School of Medicine has shown that one area of the brain is the only activity center of empathy.
Mount Sinai Researcher Receives Career-Starter Research Grant for 2012-2013
June 20, 2012
Hirofumi Morishita, MD, PhD, receives a Career-Starter Research Grant for 2012-2013 from the Knights Templar Eye Foundation.
Specific Protein Triggers Changes In Neurons In Brain Reward Center Linked To Cocaine Addiction
April 22, 2012
Eric Nestler, MD, Professor and Chair of Neuroscience, finds repeated exposure to cocaine decreases the expression of a protein necessary for normal functioning of the brain's reward system.
Gene that Causes Type 2 Diabetes May Also Cause Alzheimer’s
July 18, 2011
Researchers have found that a gene that causes diabetes kills nerve cells in the brain, possibly resulting in Alzheimer’s disease.
A Natural Chemical Found in Grape Seeds May Prevent Development or Progression of Alzheimer’s
July 15, 2011
Mount Sinai researchers found that polyphenols, a natural extract found in grapes, may help prevent or treat Alzheimer’s disease.
New Research Shows the Aging Brain Does Not Respond To Experience As Well as the Younger Brain
May 24, 2011
Mount Sinai researchers have found reduced ability of the aging brain to learn and respond to experiences, a finding that sheds new light on the aging process.
Diabetic Kidney Failure May Be Reversed with Low-Carbohydrate Diet
April 20, 2011
Researchers have found that by administering a low-carb, high-fat diet in mice, that diabetic kidney damage was reversed, and also uncovered an array of genes associated with kidney failure.
Consortium of Researchers Identify Four New Genes Linked to Alzheimer’s Disease Risk
April 3, 2011
A consortium of researchers has identified four new genes that when present increase the risk of a person developing Alzheimer’s disease later in life.
Mount Sinai Researchers Uncover How a Gene Mutation Causes Parkinson’s Disease
March 25, 2011
The new finding explains how mutations lead to the development of the most common form of Parkinson’s, providing a new diagnostic and drug target for the disease.
Researchers Find Star-Shaped Brain Cell That Support Neurons Also Aid in Formation of Long-Term Memories
March 4, 2011
Lactate, which is energy fuel produced in a type of brain cell called an astrocyte, plays a critical role in long-term memory formation.
Four Mount Sinai Researchers Awarded Prestigious "Young Investigator Grant" for Their Brain and Behavior Research
February 18, 2011
The National Alliance for Research on Schizophrenia and Depression awarded the $60,000 grants to enable the scientists to continue their work.
Mount Sinai Researchers Find That Little-Studied Gene May Boost Long-Term Memory and Enhance Cognition
January 26, 2011
Treatment with a gene called IGF-II significantly improved long-term memory. When the gene was blocked, long-term memories could not form.
Mount Sinai Researchers Learn Mechanism Behind Genetic Mutation Associated with Autism
December 17, 2010
Research shows that when a copy of a certain gene is missing, nerve cells do not effectively communicate, leading to some autism spectrum disorders.
Mount Sinai Researcher Awarded Renowned Institute of Medicine Prize for Outstanding Achievements in Improving Mental Health
October 11, 2010
Dr. Eric Nestler honored for his work and achievements in addiction science.
Mount Sinai Study Shows That Major Alzheimer’s Risk Gene Causes Alterations in Shapes of Brain Protein Deposits
July 14, 2010
A team led by Dr. Sam Gandy is presenting new research at the Alzheimer's Association International Conference on Alzheimer's Disease
Mount Sinai Honors Female Scientists with Inaugural Robin Chemers Neustein Postdoctoral Fellowship
June 30, 2010
Inaugural award supporting female scientists at Mount Sinai School of Medicine has been awarded to Molly A. Ingersoll, PhD, and Ruth I. Johnson, PhD.
New “Mouse Models” Give Insight to Gene Mutation That Is Potential Cause Of Parkinson’s Disease
March 31, 2010
Mount Sinai School of Medicine researchers are among the first to discover how gene mutations may cause Parkinson’s disease.
Mount Sinai School of Medicine Significantly Improves Its U.S. News & World Report Best Graduate Schools Rankings
April 24, 2009
Over the past four years, Mount Sinai has improved in the U.S. News & World Report "America's Best Graduate Schools" rankings more than any other school in the United States, jumping from 32nd to 22nd.
Eric J. Nestler, MD, PhD, Elected President of American College of Neuropsychopharmacology
March 25, 2009
Eric J. Nestler, MD, PhD, neuroscientist, molecular biologist, and psychiatrist, will serve as ACNP president-elect beginning in December 2009, and will serve as president beginning in December 2010.
Elizabeth Heller, PhD was chosen as one of the recipients of the 2015 Robin Chemers Neustein Postdoctoral Fellowship Award. Dr. Heller's research focuses on epigenetic remodeling - the molecular changes that occur at specific genes – in the context of drugs of abuse and stress. Read More
Addiction has been scientifically established as a disease, not an absence of willpower. Where is the latest science taking us, and what does it mean for treatment? How do we measure success?
Watch the video clip
Addiction is a disorder of the brain, not one of morality. The Friedman Brain Institute actively seeks to discover what unique characteristics make certain individuals more vulnerable to addictive disorders and which treatments may be best suited to help that individual to overcome the disease. Watch the video clip